High Dose Chemotherapy (HDT) With Busulfan, Melphalan and Topotecan Followed by Autologous Hematopoietic Stem Cell Transplantation (ASCT) in Pediatric Patients (Pts) With High Risk Solid Tumors

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2011.12.135
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Consolidation Treatment for High Risk Solid Tumors in Children With Myeloablative Chemotherapy and Autologous Hematopoietic Progenitor Stem Cell Transplantation

Revista Brasileira de Hematologia e Hemoterapia
2013English

Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

High-Dose Chemotherapy (HDC) and Autologous Hematopoietic Stem Cell Transplantation (ASCT) as Salvage Therapy for Relapsed Osteosarcoma

Bone Marrow Transplantation
TransplantationHematology
2001English

Brazilian Experience Using High-Dose Sequential Therapy (HDS) Followed by Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Malignant Lymphomas

Revista Brasileira de Hematologia e Hemoterapia
2009English

Is High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation in Breast Cancer Patients a Done Deal?

Women's Health
Medicine
2010English

A Phase I Dose Escalation Study of High-Dose Thiotepa, Melphalan and Carboplatin (TMCb) Followed by Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) in Patients With Solid Tumors and Hematologic Malignancies

Bone Marrow Transplantation
TransplantationHematology
2000English

Infectious Complications After High-Dose Chemotherapy and Autologous Stem Cell Transplantation: Comparison Between Patients With Lymphoma or Multiple Myeloma and Patients With Solid Tumors

Bone Marrow Transplantation
TransplantationHematology
2001English

Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Biochemical Markers of Cardiotoxicity of High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients With Malignant Lymphoproliferative Disorders

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy